Cares Built will debut Hercules at RSNA show

Article

Cares Built, an x-ray and general radiographic company, has received 510(k) clearance from the FDA for the Hercules 7000, its new motor-driven mobile x-ray system.The Hercules 7000 is capable of 500-mA x-rays and is designed to move between exam

Cares Built, an x-ray and general radiographic company, has received 510(k) clearance from the FDA for the Hercules 7000, its new motor-driven mobile x-ray system.

The Hercules 7000 is capable of 500-mA x-rays and is designed to move between exam rooms or to have great flexibility in one room, according to the firm. Features of the system include a one-step articulating arm with rotation and a dual power supply that enhances positioning and propulsion capabilities, said Tim Telymonde, president and CEO.

Administrators at St. Louis University Hospital have ordered the first system from the New Jersey-based company, said Kenneth Alderfer, Cares Built spokesperson. The Hercules 7000 will be displayed at this year’s Radiological Society of North America trade show in November. Cares Built also manufactures the Clarity 7000 direct digital x-ray system.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.